Morgan Lewis today announces that Steven A. Reed has joined the firm as a partner in its Litigation Practice, resident in Philadelphia.

Morgan Lewis advised Perrigo Company, a global healthcare products supplier, on its acquisition of nearly all of the assets of Paddock Laboratories, Inc. for $540 million in cash.

In a transaction valued at $587 million, Clarient, Inc. has agreed to be acquired by GE Healthcare.

BMP Sunstone and sanofi-aventis announced that they have entered into a definitive agreement where sanofi-aventis will acquire all outstanding shares of BMP Sunstone at $10 per share, or approximately $520.6 million.

Morgan Lewis placed highly among global law firms in BioPharm Insight’s second quarter licensing and mergers and acquisitions rankings.

In 2009, Morgan Lewis placed highly among global law firms in BioPharm Insight’s annual rankings of the year’s licensing and mergers and acquisitions activity.

Steve Mahinka is interviewed for a special feature on the future of the life sciences industry.

The FTC has voted unanimously to approve Pfizer's acquisition of Wyeth.

Morgan Lewis represented LEO Pharma in the $1 billion acquisition of exclusive product licensing rights and inventories from LEO Pharma by Warner Chilcott plc.

Morgan Lewis Business and Finance partner Stephen Jannetta is appointed to the Pennsylvania Bio board of directors.

Following the addition earlier this month of six healthcare partners on the East and West Coasts, Morgan Lewis today announced another seven attorneys have joined the firm, doubling the size of its FDA & Healthcare Practice.

Solidifying its position as a full-service legal resource for the life sciences industry, Morgan Lewis today announced the addition of six healthcare partners to its FDA/Healthcare Regulation Practice.

Morgan Lewis is pleased to announce the launch of the second edition of the Emerging Life Sciences Companies Deskbook.

Morgan Lewis ranked in ^PLCCross-border Quarterly 2008 Life Sciences Legal Market Review.

141 Morgan Lewis lawyers have been recognized in The Best Lawyers in America 2008.

Morgan Lewis is pleased to announce that William Jackson (Jack) Matney, Jr. and Robert W. (Bob) Busby have joined the firm as partners in the Washington, D.C. office. Mr. Matney and Mr. Busby focus on patent litigation and related patent services.

Morgan Lewis is pleased to announce that Andrew Ruskin has brought his healthcare regulatory practice to the firm. Mr. Ruskin counsels clients on the full array of regulatory issues affecting the healthcare industry.

Morgan Lewis is pleased to announce that the Life Sciences Interdisciplinary Practice and several of its attorneys are recognized in the ^PLCCross-border Life Sciences Handbook 2006/07.

Morgan Lewis attorneys represented the Carnegie Institution of Washington before the U.S. Patent & Trademark Office in obtaining U.S. Patent 6,506,559, which claims the subject matter awarded the Nobel Prize in Medicine for 2006.

Morgan Lewis is pleased to announce the addition of five partners and five associates to its global Intellectual Property Practice as of December 1.

On August 2, 2006, United States District Judge William Bassler entered a judgment on behalf of Morgan Lewis clients Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Inc.

On June 22, 2006 the Intellectual Property (IP) Law Section of the American Bar Association (ABA) held its summer meeting in Boston. Resolution 413-1, entitled State Prescription Drug Compulsory Licensing was presented, debated, and overwhelmingly passed.

Morgan Lewis sponsors BIO 2006, the world's largest gathering of biotechnology leaders.